标题
Therapy ofClostridium difficileinfection: perspectives on a changing paradigm
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 14, Issue 17, Pages 2375-2386
出版商
Informa Healthcare
发表日期
2013-09-23
DOI
10.1517/14656566.2013.838218
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clostridium difficile Infection Is Associated With Poor Outcomes in End-Stage Renal Disease
- (2016) Chaitanya Pant et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Characterization of swine isolates of Clostridium difficile in Spain: A potential source of epidemic multidrug resistant strains?
- (2013) Teresa Peláez et al. ANAEROBE
- In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden
- (2013) Mamun-Ur Rashid et al. ANAEROBE
- Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection
- (2013) A. Sarah Walker et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications
- (2013) S. B. Debast et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy
- (2013) Guy W. Neff et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- A New Strategy for the Prevention of Clostridium difficile Infection
- (2013) Amber Howerton et al. JOURNAL OF INFECTIOUS DISEASES
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of a Stable, Metronidazole-Resistant Clostridium difficile Clinical Isolate
- (2013) Tarah Lynch et al. PLoS One
- Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg- -Naphthylamide-Inhibitable Efflux Pumps
- (2012) V. Kothary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeIn VitroActivities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria
- (2012) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of LFF571 in a Hamster Model of Clostridium difficile Infection
- (2012) Anna Trzasko et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF571 in Healthy Volunteers
- (2012) Lillian S. L. Ting et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoCharacterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
- (2012) Carmela T. M. Mascio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action of and Mechanism of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compound LFF571
- (2012) J. A. Leeds et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activities of Fidaxomicin
- (2012) Ellie J. C. Goldstein et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis
- (2012) Irina Artsimovitch et al. CLINICAL INFECTIOUS DISEASES
- Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain
- (2012) Laurica A. Petrella et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin "Chaser" Regimen Following Vancomycin for Patients With Multiple Clostridium difficile Recurrences
- (2012) S. Johnson et al. CLINICAL INFECTIOUS DISEASES
- Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
- (2012) D. W. Eyre et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model
- (2012) C. H. Chilton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection
- (2012) Matthew J. LaMarche et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
- (2012) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Epidemiology, risk factors, and outcomes ofClostridium difficileinfection in kidney transplant recipients
- (2012) D. Neofytos et al. Transplant Infectious Disease
- Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
- (2012) Trevor D. Lawley et al. PLoS Pathogens
- Diverting Loop Ileostomy and Colonic Lavage
- (2011) Matthew D. Neal et al. ANNALS OF SURGERY
- Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection
- (2011) Ellie J. C. Goldstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
- (2011) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
- (2011) Kathleen M. Mullane et al. CLINICAL INFECTIOUS DISEASES
- Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
- (2011) V. Stevens et al. CLINICAL INFECTIOUS DISEASES
- Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection
- (2011) Ethan Gough et al. CLINICAL INFECTIOUS DISEASES
- Complications of colonoscopy
- (2011) Deborah A. Fisher et al. GASTROINTESTINAL ENDOSCOPY
- Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals
- (2011) Becky A. Miller et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
- (2011) K. W. Garey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients
- (2011) Colleen R. Kelly et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rifaximin Is Effective for the Treatment ofClostridium difficile—Associated Diarrhea: Results of an Open-Label Pilot Study
- (2011) David T. Rubin et al. Gastroenterology Research and Practice
- Tigecycline Exhibits Inhibitory Activity againstClostridium difficilein the Colon of Mice and Does Not Promote Growth or Toxin Production
- (2010) Robin L. P. Jump et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Management ofClostridium difficileInfection: Thinking Inside and Outside the Box
- (2010) Dale N. Gerding et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole
- (2010) Ching-Lan Lu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial
- (2010) P. Patrick Basu et al. Therapeutic Advances in Gastroenterology
- Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment
- (2009) Stuart Johnson et al. ANAEROBE
- Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe RefractoryClostridium difficileInfection
- (2009) Bjorn L. Herpers et al. CLINICAL INFECTIOUS DISEASES
- Nitazoxanide versus Vancomycin inClostridium difficileInfection: A Randomized, Double‐Blind Study
- (2009) Daniel M. Musher et al. CLINICAL INFECTIOUS DISEASES
- High Frequency of Rifampin Resistance Identified in an EpidemicClostridium difficileClone from a Large Teaching Hospital
- (2009) Scott R. Curry et al. CLINICAL INFECTIOUS DISEASES
- Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm
- (2009) H. Huang et al. CLINICAL MICROBIOLOGY AND INFECTION
- OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection
- (2008) T. J. Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin
- (2008) R. O'Connor et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of reduced susceptibility to metronidazole in Clostridium difficile
- (2008) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model
- (2008) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of Clostridium difficile Strains Isolated from Patients in Ontario, Canada, from 2004 to 2006
- (2008) H. Martin et al. JOURNAL OF CLINICAL MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started